Skip to main content

BOOTHBAY FUND MANAGEMENT, LLC

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 1549230 NEW YORK, NY

Position in VRDN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$9,939,235
+$8,135,277 QoQ
Shares Held
541,058
+547.2% QoQ
Ownership
0.478%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#47
of 215 holders
Holding Since
Jun 2022
9 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in VRDN Over Time

Shares Held

Position Value (USD)

Derivatives in VRDN

reported options exposure · as of Dec 31, 2024
CallValue
$983,421
CallShares
51,300
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BOOTHBAY FUND MANAGEMENT, LLC holds $666,641,771 across 159 Biotechnology names. VRDN ranks #14 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VRDN

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,939,235 541,058
2025-09-30 $1,803,958 83,594
2025-06-30 $2,550,678 182,452
2025-03-31 $1,958,886 145,318
2024-12-31 $983,421 51,300
2024-12-31 $2,643,888 137,918
2024-09-30 $3,338,539 146,749
2024-09-30 $1,330,875 58,500
2024-06-30 $344,765 26,500
2024-06-30 $988,760 76,000
2024-03-31 $866,745 49,500
2022-06-30 $459,329 39,700